Effectiveness of post-transplant prophylaxis with anti-hepatitis B virus (HBV) immunoglobulin in heart transplant patients with anti-HBV core antibodies and in recipients of organs from HBV core antibody positive donors

被引:0
|
作者
Cantarovich, M. [1 ]
Gianetti, N. [1 ]
Tchevenkov, J. [1 ]
Cyr, E. [1 ]
Cencic, D. [1 ]
Fontaine, G. [1 ]
Cecere, R. [1 ]
机构
[1] McGill Univ, Ctr Hlth, Montreal, PQ, Canada
来源
关键词
D O I
10.1016/j.healun.2005.11.287
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
276
引用
收藏
页码:S139 / S140
页数:2
相关论文
共 50 条
  • [1] Effectiveness of posttransplant prophylaxis with anti-hepatitis B virus immunoglobulin in recipients of heart transplant from hepatitis B virus core antibody positive donors
    Krassilnikova, Maria
    Deschenes, Marc
    Tchevenkov, Jean
    Giannetti, Nadia
    Cecere, Renzo
    Cantarovich, Marcelo
    TRANSPLANTATION, 2007, 83 (11) : 1523 - 1524
  • [2] Absence of anti-hepatitis B virus (HBV) core in HIV/HBV coinfection with advanced immunosuppression
    Avelino-Silva, V. I.
    Miraglia, J. L.
    Gomes-Gouvea, M. S.
    Pinho, J. R. R.
    Mendes-Correa, M. C.
    HIV MEDICINE, 2013, 14 (07) : 453 - 454
  • [3] Risk of Hepatitis B Virus (HBV) Reactivation and Role of Anti-Viral Prophylaxis in Lymphoma Patients with Past HBV Infection (HBV Antigen negative but anti-Hepatitis B core antibody positive) Receiving Chemo-Immunotherapy.
    Koo, Yu Xuan
    Tan, Shao Weng
    Tan, Bee Huat
    Tao, Miriam
    Chow, Wan Cheng
    Lim, Soon Thye
    BLOOD, 2008, 112 (11) : 1290 - 1290
  • [4] Use of hepatitis B virus (HBV) core antibody positive donors does not increase the risk of recurrent HBV in recipients undergoing OLT for HBV.
    Han, SH
    Swenson, K
    Seu, P
    Göss, J
    Yersiz, H
    Carson, M
    Farmer, D
    Drazan, K
    Ghobrial, R
    Markman, J
    Martin, P
    Busuttil, RW
    HEPATOLOGY, 1998, 28 (04) : 348A - 348A
  • [5] Should Higher Doses of Anti-Hepatitis B Virus (HBV) Therapy Be Considered Post-Liver Transplant (LTx) in HBV DNA Positive Recipients: A Case Report?
    Patel, Vishal
    Mukerji, Amar
    Karachristos, Andreas
    Maloo, Manoj
    Jain, Ashokkumar
    LIVER TRANSPLANTATION, 2013, 19 : S167 - S168
  • [6] Isolated anti-HBV core phenotype in anti-HCV-positive patients is associated with hepatitis C virus replication
    Wedemeyer, H
    Cornberg, M
    Tegtmeyer, B
    Frank, H
    Tillmann, HL
    Manns, MP
    CLINICAL MICROBIOLOGY AND INFECTION, 2004, 10 (01) : 70 - 72
  • [7] Hepatitis B core-related antigen to detect hepatitis B virus (HBV) reactivation in heart transplant recipients with past HBV infection: A pilot study
    Iossa, Domenico
    Vitrone, Martina
    Liotti, Antonietta
    Portella, Giuseppe
    Durante-Mangoni, Emanuele
    Zampino, Rosa
    CLINICAL TRANSPLANTATION, 2019, 33 (06)
  • [8] Hepatitis B infection (HBV) and risk of transmission from hepatitis B (core) antibody positive donor kidneys in renal transplant recipients.
    Shidban, H
    Aswad, S
    Naraghi, R
    Sabawi, M
    Mendez, RG
    Mendez, R
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 378A - 378A
  • [9] Vertical Transmission of Hepatitis B Virus (HBV) from Mothers Negative for HBV Surface Antigen and Positive for Antibody to HBV Core Antigen
    Walz, Alexander
    Wirth, Stefan
    Hucke, Juergen
    Gerner, Patrick
    JOURNAL OF INFECTIOUS DISEASES, 2009, 200 (08): : 1227 - 1231
  • [10] Clearance of persistent hepatitis B virus infection in Chinese bone marrow transplant recipients whose donors were anti-hepatitis B core- and anti-hepatitis B surface antibody-positive
    Lau, GKK
    Liang, R
    Lee, CK
    Yuen, ST
    Hou, JL
    Lim, WL
    Williams, R
    JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (06): : 1585 - 1591